11![Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression](https://www.pdfsearch.io/img/28ffaff1b4b75faa0df667a68d0cb2f3.jpg) | Add to Reading ListSource URL: www.molecular-cancer.comLanguage: English |
---|
12![](https://www.pdfsearch.io/img/539adce9076fd781b1894266d866140c.jpg) | Add to Reading ListSource URL: cwagwisconsin.orgLanguage: English - Date: 2012-12-26 13:26:21
|
---|
13![Draft Agenda_ENCePP Plenary_30Jun2011 Draft Agenda_ENCePP Plenary_30Jun2011](https://www.pdfsearch.io/img/c8a70f9e56ef9144eb822ae8ce049658.jpg) | Add to Reading ListSource URL: www.encepp.euLanguage: English - Date: 2015-04-27 04:26:12
|
---|
14![ENCePP response DP communication European Commission ENCePP response DP communication European Commission](https://www.pdfsearch.io/img/173ace4f5f4a649f91a5ac8f34df3eb2.jpg) | Add to Reading ListSource URL: www.encepp.euLanguage: English - Date: 2015-04-27 04:26:05
|
---|
15![Microsoft Word - KWB2006-2c.doc Microsoft Word - KWB2006-2c.doc](https://www.pdfsearch.io/img/426389683cafd6f2467ede30d644456e.jpg) | Add to Reading ListSource URL: www.lareb.nlLanguage: English |
---|
16![20 AugustUPDATE TO PRODUCT INFORMATION FOR AVANDIA® (ROSIGLITAZONE) AVANDAMET® (ROSIGLITAZONE AND METFORMIN) Dear Healthcare Professional, 20 AugustUPDATE TO PRODUCT INFORMATION FOR AVANDIA® (ROSIGLITAZONE) AVANDAMET® (ROSIGLITAZONE AND METFORMIN) Dear Healthcare Professional,](https://www.pdfsearch.io/img/91402e60b5924fb3ee569ac91d6ab6ab.jpg) | Add to Reading ListSource URL: www.nzssd.org.nzLanguage: English - Date: 2009-12-13 19:01:08
|
---|
17![16 FebruaryDear Healthcare Professional Suspension of rosiglitazone-containing medicines: Avandia. Medsafe and MARC advise: • 16 FebruaryDear Healthcare Professional Suspension of rosiglitazone-containing medicines: Avandia. Medsafe and MARC advise: •](https://www.pdfsearch.io/img/b4861721e0d521074164cbc177476a5c.jpg) | Add to Reading ListSource URL: www.medsafe.govt.nzLanguage: English - Date: 2011-02-16 15:59:40
|
---|
18![Food and Drug Administration / Clinical research / Drug safety / Pharmacy / Adverse Event Reporting System / Pharmacovigilance / Pharmaceutical industry / Rosiglitazone / Clinical trial / Pharmaceutical sciences / Pharmacology / Research Food and Drug Administration / Clinical research / Drug safety / Pharmacy / Adverse Event Reporting System / Pharmacovigilance / Pharmaceutical industry / Rosiglitazone / Clinical trial / Pharmaceutical sciences / Pharmacology / Research](/pdf-icon.png) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
19![AprilPatent Monopolies and the Costs of Mismarketing Drugs By Ravi Katari and Dean Baker* AprilPatent Monopolies and the Costs of Mismarketing Drugs By Ravi Katari and Dean Baker*](https://www.pdfsearch.io/img/ff309c4f58a6d7170ebad2bcbd385ff5.jpg) | Add to Reading ListSource URL: www.cepr.netLanguage: English - Date: 2015-04-27 16:52:50
|
---|
20![Chemistry / Fenofibrate / Metabolic syndrome / Metformin / Diabetes mellitus / Diabetes management / Rosiglitazone / Anti-diabetic medication / Impaired fasting glucose / Diabetes / Medicine / Health Chemistry / Fenofibrate / Metabolic syndrome / Metformin / Diabetes mellitus / Diabetes management / Rosiglitazone / Anti-diabetic medication / Impaired fasting glucose / Diabetes / Medicine / Health](/pdf-icon.png) | Add to Reading ListSource URL: www.diabetesclinic.caLanguage: English - Date: 2007-07-06 10:46:26
|
---|